31,500 Shares in CVS Health Corporation $CVS Purchased by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. purchased a new position in CVS Health Corporation (NYSE:CVS) during the second quarter, HoldingsChannel reports. The fund purchased 31,500 shares of the pharmacy operator’s stock, valued at approximately $2,173,000.

Other institutional investors have also added to or reduced their stakes in the company. Jennison Associates LLC grew its stake in CVS Health by 503.8% during the first quarter. Jennison Associates LLC now owns 1,896,341 shares of the pharmacy operator’s stock valued at $128,477,000 after acquiring an additional 1,582,257 shares in the last quarter. Cantor Fitzgerald Investment Advisors L.P. grew its position in shares of CVS Health by 1.6% during the second quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock valued at $28,264,000 after purchasing an additional 6,615 shares in the last quarter. Cerity Partners LLC lifted its position in shares of CVS Health by 25.0% in the first quarter. Cerity Partners LLC now owns 648,266 shares of the pharmacy operator’s stock worth $43,920,000 after buying an additional 129,535 shares in the last quarter. Brandywine Global Investment Management LLC boosted its stake in CVS Health by 20.1% during the first quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock valued at $231,808,000 after buying an additional 572,533 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its holdings in CVS Health by 122.5% during the 1st quarter. Skandinaviska Enskilda Banken AB publ now owns 565,152 shares of the pharmacy operator’s stock valued at $38,289,000 after buying an additional 311,098 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.22% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Sanford C. Bernstein upped their price objective on CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Piper Sandler upped their price target on shares of CVS Health from $81.00 to $99.00 in a research note on Friday. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday. Cantor Fitzgerald boosted their target price on shares of CVS Health from $78.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, October 30th. Finally, Raymond James Financial increased their price target on shares of CVS Health from $75.00 to $90.00 in a report on Friday. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $88.82.

CVS Health Price Performance

CVS stock opened at $78.48 on Tuesday. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83. The company has a 50-day moving average price of $76.64 and a 200 day moving average price of $69.12. The stock has a market cap of $99.62 billion, a PE ratio of 206.52, a P/E/G ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is currently 700.00%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.